Molecular Diagnostics Market 2023 Foreseen | PCR Technology Booming Growth of the Market by QIAGEN N.V., Hologic, Grifols, Abbott, Siemens Healthcare GmbH, Etc Industry Players

Market Research Future published a half-cooked research report on Global Molecular Diagnostics Market. Report include Molecular Diagnostics Market in-depth analysis, future predictions, Industry size, share, and growth rate. The global molecular diagnostics market is expected to grow at a CAGR of 9.6% during forecasted period 2017-2023.

Molecular diagnostics is an integral part of in-vitro diagnostics, the collection of techniques used to analyse biomarkers in genomics and proteomics. Molecular diagnostics plays a major role in early diagnosis and treatment of diseases. Molecular diagnostics is an important tool when it is necessary to diagnose and treat at molecular level.

Increasing prevalence of infectious diseases and various types of cancer, and advancement in molecular techniques are the major driving forces for the growth of the market. The PCR technology has completely transformed the growth of the market. Molecular diagnostics includes automated and easy-to-handle techniques.

All these factors are responsible for growth of the market positively. Furthermore, increasing prevalence of infectious diseases like influenza and human papillomavirus and others also boost the growth of the market. On the other hand, higher price of molecular diagnostic kits may hinder the growth of the market.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1171

Key players for Global Molecular Diagnostics Market

Market Research Future (MRFR) recognizes the following companies as the key players in Molecular Diagnostics Market: There are plenty of large and small market players which operate in this market all over the globe.

Hoffmann-La Roche Ltd. (U.S.), QIAGEN N.V. (the Netherlands), Hologic, Inc. (U.S.), Grifols (Spain), Abbott (U.S.), Siemens Healthcare GmbH (Germany), Bio-Rad Laboratories, Inc. (US), BD (U.S.), Beckman Coulter Inc. (U.S.), bioMérieux SA (France), and Cepheid (U.S.).

Segmentation for Global Molecular Diagnostics Market

The global molecular diagnostics market is segmented on the basis of techniques, applications and end users.

Based on the techniques, it is segmented into PCR (Polymerase Chain Reaction) and real-time PCR, fluorescence in-situ hybridization, microarray, transcription-mediated amplification, and next-generation sequencing.

On the basis of applications, it is segmented into infectious diseases, oncology, blood screening, genetic testing, pharmacogenomics, human leukocyte antigen typing, coagulation, others.

And on the basis end users, it is segmented into hospitals, diagnostic laboratories, academics and research institutions.

Regional Analysis for Global Molecular Diagnostics Market

On regional basis, the molecular diagnostics market is segmented into America, Europe, Asia Pacific and Middle East & Africa.

America dominates the global market for molecular diagnostics due to increasing demand for the advanced techniques and molecular diagnostics and higher expenditure in life science domain are the major factors for the growth of American market. Moreover, due to well-developed technology, increasing patient with bone disorders, high healthcare spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region

Europe records the second largest market share followed by Asia Pacific. Increasing prevalence of lifestyle and chronic diseases, increasing number of private diagnostic centres are the major factors responsible for growth of the market. Lack of proper reimbursement policies in the developing countries and strict FDA regulations are the main restraints for the growth of molecular diagnostics market.

Get an Exclusive Discount on Report @ https://www.marketresearchfuture.com/check-discount/1171

According to American Cancer Society, Asia Pacific region, contributes 44% of all cancer cases (6.4 million out of 14.1 million) and 51% of all cancer deaths (4.3 million out of 8.2 million) globally, whereas China representing the majority of the cancer burden. Incidence rates vary, being highest in the Republic of Korea (307.8 per 100,000). Furthermore, increasing demand for quality devices in the healthcare projected to lead to the use of advanced equipment, which, in turn, will increase the market growth of the molecular diagnosticsr in the region.

On the other hand, in the Middle East and Africa, blood disorders have become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment

Few Brief Table Of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Molecular Diagnostics Market, By Type Of Technique

Chapter 7. Global Molecular Diagnostics Market, By Applications

Chapter 8. Global Molecular Diagnostics Market, By End User

Chapter 9. Global Molecular Diagnostics Market, By Region

Chapter 10 Company Landscape

Chapter 11 Company Profiles

Chapter 12 MRFR Conclusion

Chapter 13 Appendix

TOC Continued…

Do You Have Query? Ask To Our Experts @ https://www.marketresearchfuture.com/enquiry/1171

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.